June 30, 2025 · Form 4 insider transaction
Prince Joshua S. bought 4,882 shares of Vistagen Therapeutics, Inc. at $1.70 per share, a transaction worth $8.3K. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 1 day after the transaction.
The Reporting Person is voluntarily reporting the acquisition of shares under the Issuer's 2019 Employee Stock Purchase Plan, as amended, in a transaction exempt under Rule 16b-3(c) and Rule 16b-3(d).